Medicated Skin Care in France

April 2012 | 42 pages | ID: M06947ADA4EEN
Euromonitor International Ltd

Abstracts

French consumers are increasingly confident to self-medicate with OTC medicated skin care products, in particular with those that are herbal based. In order to treat minor ailments, they do not want to lose time going to doctors. Even so, some of them still prefer semi-ethical drugs and Rx medicines because they are reimbursed.

Euromonitor International's Medicated Skin Care in France report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Medicated Skin Care market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

MEDICATED SKIN CARE IN FRANCE

Euromonitor International
April 2012

LIST OF CONTENTS AND TABLES

Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of Medicated Skin Care by Category: Value 2006-2011
  Table 2 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  Table 3 Medicated Skin Care Company Shares by Value 2007-2011
  Table 4 Medicated Skin Care Brand Shares by Value 2008-2011
  Table 5 Hair Loss Treatments Brand Shares by Value 2008-2011
  Table 6 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  Table 7 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016
Bayer Sante Familiale Sas in Consumer Health (france)
Strategic Direction
Key Facts
  Summary 1 Bayer Santé Familiale SAS: Key Facts
  Summary 2 Bayer Santé Familiale SAS: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 3 Bayer Santé Familiale SAS: Competitive Position 2011
Cooperation Pharmaceutique Francaise Sas (cooper) in Consumer Health (france)
Strategic Direction
Key Facts
  Summary 4 Cooperation Pharmaceutique Francaise SAS (Cooper): Key Facts
  Summary 5 Cooperation Pharmaceutique Francaise SAS (Cooper): Operational Indicators
Company Background
Production
  Summary 6 Cooperation Pharmaceutique Francaise SAS (Cooper): Production Statistics 2011
Competitive Positioning
  Summary 7 Cooperation Pharmaceutique Francaise SAS (Cooper): Competitive Position 2011
Juva Santé, Laboratoires in Consumer Health (france)
Strategic Direction
Key Facts
  Summary 8 Laboratoires Juva Santé: Key Facts
  Summary 9 Laboratoires Juva Santé: Operational Indicators
Company Background
Production
  Summary 10 Laboratoires Juva Santé: Production Statistics 2011
Competitive Positioning
  Summary 11 Laboratoires Juva Santé: Competitive Position 2011
Laboratoires Mcneil in Consumer Health (france)
Strategic Direction
Key Facts
  Summary 12 Laboratoires McNeil: Key Facts
  Summary 13 Laboratoires McNeil: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 14 Laboratoires McNeil: Competitive Position 2011
Pierre Fabre Sa, Laboratoires in Consumer Health (france)
Strategic Direction
Key Facts
  Summary 15 Laboratoires Pierre Fabre SA: Key Facts
  Summary 16 Laboratoires Pierre Fabre SA: Operational Indicators
Company Background
Production
  Summary 17 Laboratoires Pierre Fabre SA: Production Statistics 2011
Competitive Positioning
  Summary 18 Laboratoires Pierre Fabre SA: Competitive Position 2011
Executive Summary
Consumer Health Registers Low But Positive Value Growth in 2011
Ageing Population and Concentration in Urban Areas, Key Growth Drivers
Direct Selling and Herbal Products Behind Best-performing Operators
Pharmacies Still the Most Common Retailer for Consumer Health Products
Modest Growth Expected Over the Forecast Period
Key Trends and Developments
Hectic Lifestyles Behind Good Performances of Some Categories of OTC Drugs
Ageing Population A Major Driver for Consumer Health
Weight Management, the Most Affected by the Weak Economic Context
Transfer of Rx Drugs To OTC Market Continues To Boost Growth Potential
French Consumers Increasingly Receptive To Oral Nrt Smoking Cessation Aids
Market Indicators
  Table 8 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  Table 9 Life Expectancy at Birth 2006-2011
Market Data
  Table 10 Sales of Consumer Health by Category: Value 2006-2011
  Table 11 Sales of Consumer Health by Category: % Value Growth 2006-2011
  Table 12 Consumer Health Company Shares 2007-2011
  Table 13 Consumer Health Brand Shares 2008-2011
  Table 14 Penetration of Private Label by Category 2006-2011
  Table 15 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  Table 16 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
  Table 17 Forecast Sales of Consumer Health by Category: Value 2011-2016
  Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Advertising
Packaging and Labelling
Distribution
Vitamins and Dietary Supplements Registration and Classification
EU Legislation
Self-medication/self-care and Preventive Medicine
Generics
Switches
  Summary 19 OTC - Switches 2009-2011
Definitions
Sources
  Summary 20 Research Sources